Skytrofa’s once weekly dose for growth hormone deficiency depends on your child’s body weight and response to the drug. It is important to follow the Skytrofa dosage a doctor prescribes. Skytrofa is a ...
Skytrofa (lonapegsomatropin-tcgd) is a prescription drug that’s used to treat growth hormone deficiency (GHD) in certain children. It’s given by injection under the skin once weekly. Skytrofa is a ...
Overview: Skytrofa is used to increase the levels of human growth hormone in people with growth hormone deficiency. It works similarly to the body's natural human growth hormone to stimulate growth.
COPENHAGEN, Denmark, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), today announced the U.S. commercial launch of SKYTROFA (lonapegsomatropin-tcgd), its once-weekly treatment ...
The approval was based on data from the phase 3 heiGHt trial, which compared Skytrofa to somatropin in 161 treatment-naïve, prepubertal patients with growth hormone deficiency. Skytrofa ® ...
Ascendis Pharma announced that the US Food and Drug Administration (FDA) has approved Skytrofa (lonapegsomatropin-tcgd) for the treatment of pediatric patients one year and older who weigh at least 11 ...
The approval was based on data from the phase 3 heiGHt trial that assessed Skytrofa in 161 treatment-naïve, prepubertal patients with growth hormone deficiency. The Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback